Croci I, Byrne N, Chachay V, Hills, A, Clouston A, O’Moore-Sullivan T, Prins JB, Macdonald GA, Hickman IJ. Independent Effects of Diet and Exercise Training on Fat Oxidation in NAFLD World Journal of Hepatology, 2016 In Press

Chikani V, Cuneo RC, Hickman IJ, Ho KK. GH enhances anaerobic capacity: Impact on physical function and quality of life in adults with GH deficiency. Clin Endocrinol. 2016 Jun 27.

Knight BA, Hickman IJ, Gibbons K, McIntyre HD. Quantitative assessment of dietary intake in adults with Type 1 diabetes following flexible insulin therapy education with an active promotion of dietary freedom. Diabetes Res Clin Pract. 2016 Jun;116:36-42

Lassemillante AM, Oliver V, Hickman IJ, Murray E, Campbell KL. Meal replacements as a strategy for weight loss in obese hemodialysis patients. Hemodial Int. 2016 Apr 4.

Whelan M, Wright O, Hickman IJ. Effect of dietary composition on fasting substrate oxidation in obesity Critical Reviews food science and nutrition 2016 Jan 2;56(1):146-51 (IF 4.789)

Hickman IJ, Cotugno J, Lassimellente A, Ferguson M. Am I making a difference? Measuring outcomes in clinical practice.  European Journal of Clinical Nutrition 2015 Nov;69(11):1181-3.  (IF2.71)

Nevin A, Steenson J, Vivanti A, Hickman IJ. Investigation of measured and predicted resting energy needs in adults after spinal cord injury: a systematic review. Spinal Cord. 2016 Apr;54(4):248-53 (IF 1.804)

Ipavec-Levasseur S, Croci I, Choquette S, Byrne NM, Cowin G, O’Moore-Sullivan TM, Prins JB, Hickman IJ. Effect of 1hr moderate intensity aerobic exercise on intramyocellular lipids of obese men before and after a lifestyle intervention. Applied Physiology, Nutrition and Metabolism 2015 Dec;40(12):1262-8. (IF2.009)

Cotugno, JD, Ferguson M, Hardern H, Colquist S, Stack A, Zimmerman J, Russell AW, Ball LE, Hickman IJ. “I wish they could be in my shoes”: Patient insights into tertiary health care for type 2 diabetes. In Press Patient preference and adherence 2015 Nov 17;9:1647-55. (IF1.72)

Whelan M, Goode A, Leenert V, Winkler E, Eakin E, Hickman IJ, Reeves, M. Feasibility, effectiveness, and cost-effectiveness of a telephone-based weight loss program delivered via a hospital outpatient setting. Translational Behavioral Medicine: Practice, Policy and Research In Press July 2015

Chikani V, Cuneo R, Hickman IJ, Ho KK. Impairment of anaerobic capacity in adults with growth hormone deficiency J Clin Endocrinol Metab 2015:100(5):1811-8 (IF 6.21)

Croci I, Hickman IJ, Wood RE, Borrani F, Macdonald GA and Byrne NM. Fat oxidation over a range of exercise intensities: fitness vs fatness. Appl Physiol Nutr Metab 2014:39(12):1352-9. (IF 2.009)

Hickman IJ, Byrne NM, Croci I, Chachay VS, Clouston AD, Hills AP, Bugianesi E, Whitehead JP, Gastaldelli A, O'Moore-Sullivan TM, Prins JB and Macdonald GA (2013) A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis. J Diabetes Metab 4: 300.doi:10.4172/2155-6156.1000300

Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. Resveratrol does not benefit patients with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014 Dec;12(12):2092-103. (IF 7.896)

Croci I, Borrani F, Byrne N, Wood R, Hickman IJ, Cheneviere X, Malatesta D. Reproducibility of Fatmax and fat oxidation rates during exercise in recreationally trained males PlosOne 2014:9(6): e97930. doi:10.1371/journal.pone.0097930 (IF 3.234)

Murray E, McCoy S, Campbell K, Hickman IJ. Modern day challenges for the nutrition management of liver transplant recipients. Nutrition and Dietetics, 2014:71(2):86-91.

Adriani A, Repici A, Hickman IJ, Pellicano R. Helicobacter pylori infection and respiratory diseases: actual data and directions for future studies. Minerva Med 2014;105(1):1-8.

Hickman IJ. Scientific peer review in publishing (Invited commentary). Nutrition and Dietetics. 2013;70(2):92-93. (IF 0.8)

Wright ORL, Hickman IJ, Petchey WG, Sullivan CM, Ong C, Rose FJ, Ng C, Prins JB, Whitehead JP, O'Moore-Sullivan TM. The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin? Canadian Journal of Physiology and Pharmacology, 2013, 91(6): 496-501  (IF 1.95)

Phillips LK, Peake JM, Zhang X, Hickman IJ, Briskey DR, Huang BE, Simpson P, Li SH, Whitehead JP, Martin JH, Prins JB. Postprandial total and HMW adiponectin following a high-fat meal in lean, obese and diabetic men. Eur J Clin Nutr 2013;67(4):377-84 (IF 2.76)

Centis E, Marzocchi R, Suppini A, Dalle Grave R, Villanova N, Hickman IJ, Marchesini G. The role of lifestyle change in the prevention and treatment of NAFLD. Curr Pharm Des 2013;19(29):5270-9 (IF 3.87) 

Croci I, Byrne NB, Choquette S, Hills AP, Chachay VS, O’Moore-Sullivan TM, Macdonald GA, Prins JB, Hickman IJ. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease GUT, 2012;62(11):1625-33 (IF 10.73)

Petchey WG, Hickman IJ, Prins JB, Hawley CM, Johnson DW, Isbel NM. Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomised controlled trial. Nephrology 2013;18(1):26-35 (IF 2.18)

Hickman IJ, Byrne NB, Macdonald GA. Physical activity and cardiovascular fitness in patients with NAFLD. Chapter in: Nonalcoholic Fatty Liver Disease: A Practical Guide 2012 In Press

Hickman IJ and Whitehead JP. Structure and signalling and physiologic role of adiponectin – Dietary and exercise-related variations. Invited Review, Current Medicinal Chemistry 2012;19(32):5427-43 (IF 4.86)

Kee AL, Isenring E, Hickman IJ, Vivanti A. Resting energy expenditure of morbidly obese using indirect calorimetry: A systematic review. Obesity Reviews 2012 Sep;13(9):753-65 (IF 7.038)

Chachay V, Kirkpatrick C, Hickman I, Ferguson M, Prins J, Martin J. Resveratrol – pills to replace a healthy diet? British Journal of Clinical Pharmacology 2011 Jul;72(1):27-38. (IF 3.246)

Moscatiello S, Di Luzio R, Bugianesi E, Suppini A, Hickman I, Di Domizio S, Dalle Grave R, Marchesini G. Cognitive-Behavioral Treatment of Nonalcoholic Fatty Liver Disease: A Propensity Score-Adjusted Observational Study. Obesity 2011;19(4):763-70 (IF 3.99)

Rossi M and Hickman I. Review article: Diet prescription for Non-Alcoholic Fatty Liver Disease: Is it worth the effort? A systematic review. Nutrition & Dietetics 2011;68:33-40. (IF 0.8)

Phillips LK, Peake JM, Zhang X, Hickman IJ, Kolade O, Sacre JW, Huang BE, Simpson P, Li SH, Whitehead JP, Sharman JE, Martin JH, Prins JB. The Effect of a High-Fat Meal on Postprandial Arterial Stiffness in Men with Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2010 Sep;95(9):4455-9. (IF 6.5)

Orazio L, Isbel N, Armstrong K, Tarnarskyj J, Johnson D, Hale R, Kaisar M, Banks M and Hickman I. Evaluation of Dietetic Advice as part of Multidisciplinary Lifestyle Intervention for modification of Cardiovascular Disease Risk Factors in Renal Transplant Recipients with Abnormal Glucose Tolerance. Journal of Renal Nutrition 2011 Nov;21(6):462-71 (IF:1.62)

Ipavec-Levasseur S, Byrne NM, Cowin G, Hickman IJ, O’Moore-Sullivan TM, Prins JB. Exercise training and intramyocellular lipids in a female subject with McArdle disease. In Press  Metabolism: Clinical and Experimental (IF 2.92)

Petchey WG, Hickman IJ, Johnson DW, Isbel NM. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial BMC Nephrology 2009, 10:41

Hickman IJ, Sullivan CM, Flight S, Campbell C, Crawford DH, Masci PP, O’Moore-Sullivan TM, Prins JB, Macdonald GA. Altered clot kinetics in patients with non-alcoholic fatty liver disease. Annals of Hepatology 2009 Oct-Dec;8(4):331-8. (IF 1.81)

Vanni, E. Abate, ML, Gentilcore E, Hickman IJ, Gambino R, Cassader M, Smedile A, Ferrannini E, Rizzetto M, Marchesini G, Gastaldelli A and Bugianesi E, Sites and mechanisms of insulin resistance in non-obese, non-diabetic patients with Chronic Hepatitis C. Hepatology 2009: 50(3):697-706 (IF: 12.0) Editorial: Milner KL, Chisholm D and George J: The many faces of Hepatitis C: Liver disease and type 2 diabetes Hepatology 2009:50(3):668-70.

Venkatesh B, Hickman I, Nisbet J, Cohen J and Prins J. Changes in serum adiponectin concentrations in critical illness: A preliminary investigation. Critical Care Medicine 2009;13(4):R105 (IF 6.23)

Hickman IJ. Obesity management in liver clinics: What’s your style of lifestyle intervention? Invited Editorial. Journal of Gastroenterology and Hepatology 2009; Mar;24(3):327-8 (IF: 3.33)

Hickman IJ. Training dietitians for competent obesity management: Reignite traditional skills and intertwine with new technologies. Invited Editorial Nutrition and Dietetics 2009;66(1):2-3. (IF: 0.8)

Orazio L, Hickman I, Armstrong K, Johnson D, Banks M and Isbel N.Higher levels of physical activity are associated with lower prevalence of abnormal glucose tolerance in renal transplant recipients, Journal of Renal Nutrition, 2009;19(4):304-13. (IF: 1.62)

Colley RC, Hills AP, O'Moore-Sullivan TM, Hickman IJ, Prins JB, Byrne NM. Variability in adherence to an unsupervised exercise prescription in obese women. International Journal of Obesity, 2008 May;32(5):837-44  (IF: 5.22)

Hickman IJ, Russell AJ, Prins JB, Macdonald GA. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease? Diabetes Res Clin Pract. 2008 Apr;80(1):e10-2  (IF: 2.62)

Hickman IJ and Macdonald GA. Is Vitamin E beneficial in chronic liver disease? Invited Editorial Hepatology 2007 Aug;46(2):288-90  (IF: 12.0)

Hickman IJ and Macdonald GA. The impact of diabetes on the severity of liver disease. The American Journal of Medicine Invited Review 2007 Oct;120(10):829-834.  (IF: 4.91)

Venkatesh B, Cohen J, Hickman I, Nisbet J, Thomas P, Ward G, Hall J, Prins J. Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med. 2007 Oct;33(10):1746-53.  (IF: 5.26)

Orazio L, Armstrong K, Banks M, Isbel, N Hickman IJ. Central obesity is common in renal transplant recipients and associated with increased prevalence of cardiovascular risk factors. Nutrition and Dietetics 2007;64:200-206  (IF: 0.8)

Osland E, Powell E, Banks M, Jonsson J, Hickman IJ. Obesity management in liver clinics: Translation of research into clinical practice. Journal of Gastroenterology and Hepatology 2007;22(4):504-9. Editorial: Chan HLY and Wong VWS Can dietetic intervention for obesity ever succeed in real life? 2007;22(4):459-450.  (IF: 3.33)

Hickman IJ, Whitehead JP, Prins JB and Macdonald GA. Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 2007;9(3):438-40.  (IF: 5.18)

Venkatesh B, Prins J, Torpy D, Chapman M, Joyce C, Cooper DJ, Cohen J, Hickman I, Jones D, Higgins A. Relative adrenal insufficiency in sepsis: match point or deuce? Crit Care Resusc. 2006 Dec;8(4):376-80 (IF 1.67)

Hickman IJ*, Richards AA*, Wang AYH, Jones AL, Newell F, Mowry BJ, Whitehead JP, Prins JB, Macdonald GA. Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia. Journal of Clinical Psychopharmacology 2006 Jun;26(3):232-7. *equal 1st author contribution (IF: 6.85)

Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin – a Key Adipokine in the Metabolic Syndrome. Review Diabetes, Obesity and Metabolism 2006; 8(3):264-280. (IF: 5.18)

Wang A Y-H, Hickman IJ, Richards AA, Whitehead JP, Prins JB, Macdonald GA. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. American Journal of Gastroenterology 2005;100:2717-2723. (IF: 7.55)

Jonsson J, Moschen A, Hickman I, Richardson M, Clouston A, Powell E, Tilg H. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol. 2005 Dec;43(6):929-36.  (IF: 8.90)

Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004 Mar;53(3):413-9.  (IF: 10.73)

I Hickman, E Powell, A Clouston, J Prins, D Purdie, S Ash and J Jonsson. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol. 2003 Dec;39(6):1042-8.  (IF: 8.90)

I Hickman and E Powell, Invited Review Article, Fatty liver disease: How to identify and manage it, Medicine Today, 2003;4(2):40-48.

I Hickman, A Clouston, G Macdonald, D Purdie, J Prins, S Ash, J Jonsson, and E Powell. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 2002;51(1):89-94. Editorial: Heathcote J. Weighty issues in hepatitis C Gut. 2002 Jul;51(1):7-8. (IF: 10.73)

A Clouston, I Hickman, G Macdonald, J Jonsson, E Powell. Reply to Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? Journal of Hepatology, 2001;35(3):432-433.  (IF: 8.90)

S Capra, I Hickman, M Hannah-Jones, J Payne. An innovative strategy for developing competence in foodservice management. Focus on Health Professional Education, 2002;4(2):39-47. (IF 0.9)

J Payne, S Capra, I Hickman. Residential camps as a setting for nutrition education of Australian girls. Aust NZ J Public Health, 2002,Aug;26(4):383-8. (IF: 1.64)